US2003152546A1PendingUtilityA1
Absorbable E-caprolactone polymers and medical devices
Priority: Mar 11, 1994Filed: Oct 21, 2002Published: Aug 14, 2003
Est. expiryMar 11, 2014(expired)· nominal 20-yr term from priority
Inventors:Shalaby W. Shalaby
C08G 63/912A61L 29/085A61L 17/145A61L 27/18A61L 24/046A61L 27/34A61L 17/12A61L 27/50
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Crystalline, low melting ε-Caprolactone polymers which undergo accelerated hydrolysis, and their use as lubricant coatings and/or as coatings containing bioactive agents, as carriers of viable cells, and as coatings for open-cell microporous template or constucts for tissue regeneration; the polymers bearing basic functionalities can be linked tonically or covalently to the ester chain which induces autocatalyzed hydrolysis.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A bioabsorbable, lubricant coating for medical devices such as surgical staples; facia fasteners and other surgical closure devices; trocars, syringes; endoscopes and endoscopic catheters, instruments and devices; surgical implants; vascular grafts; shunts; and stents; an open cell, microporous template for tissue regeneration; a matrix for peptides and proteins; a matrix for vaccines and growth factor; and a bioabsorbable carrier for viable cells, said coating comprising crystalline nitrogenous polyesters comprising predominantly ε-caprolactone polymer sequences linked ionically or covalently to amine-bearing structures which represent 1 to 20 percent of the total weight.
2 . A lubricant coating as in claim 1 , further comprising a bioactive agent.
3 . A lubricant coating as in claim 2 , wherein the bioactive agent is an anti-microbial.
4 . A bioabsorbable, lubricant coating for a surgical closure device as in claim 1 , wherein the device is a suture, and the coating comprises a crystalline nitrogenous polyester comprising predominantly ε-caprolactone polymer sequences linked tonically or covalently to amine-bearing structures which represent 1 to 20 percent of the total weight, and wherein the polyester chain is terminated with a carboxyl group and wherein the polyester is tonically linked to arginine.
5 . A bone wax comprising crystalline nitrogenous polyesters polymers comprising predominantly ε-caprolactone polymer sequences linked tonically or covalently to amine-bearing structures which represent 1 to 20 percent of the total weight.
6 . A tissue sealant comprising crystalline nitrogenous polyesters polymers comprising predominantly ε-caprolactone polymer sequences linked ionically or covalently to amine-bearing structures which represent 1 to 20 percent of the total weight.
7 . A bioabsorbable carrier as in claim 9 , further comprising a growth factor.
8 . A hemostatic agent comprising crystalline nitrogenous polyester polymers comprising predominantly ε-caprolactone polymer sequences linked ionically or covalently to amine-bearing structures which represent 1 to 20 percent of the total weight.
9 . A hemostatic agent as in claim 8 , further comprising multivalent metal ions.
10 . A component for therapeutic or prophylactic system for managing orthopedic, vascular or dental infection, said component comprising nitrogenous polyester polymers comprising predominantly ε-caprolactone polymer sequences linked ionically or covalently to amine-bearing structures which represent 1 to 20 percent of the total weight.Join the waitlist — get patent alerts
Track US2003152546A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.